These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10723345)

  • 21. Impact of single-needle therapy in new chronic hemodialysis starts for individuals with arteriovenous fistulae.
    Wilson B; Harwood L; Thompson B
    CANNT J; 2009; 19(2):23-8. PubMed ID: 19606649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More vein, less plastic.
    Francis DM
    Nephrology (Carlton); 2005 Feb; 10(1):10-4. PubMed ID: 15705175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should arteriovenous access flow undergo regular surveillance?
    Whittier WL
    Semin Dial; 2011; 24(4):389-90. PubMed ID: 21851396
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary embolism following thrombolysis of dialysis access: is anticoagulation really necessary?
    Calderon K; Jhaveri KD; Mossey R
    Semin Dial; 2010; 23(5):522-5. PubMed ID: 21039878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations at initiation of cannulation.
    Mott S
    Nephrol News Issues; 2013 Mar; 27(3):26, 28. PubMed ID: 23581173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What should nephrologists do to maximize the use of arteriovenous fistulas?
    Francisco L
    Semin Dial; 2006; 19(3):205-7. PubMed ID: 16689970
    [No Abstract]   [Full Text] [Related]  

  • 28. What should nephrologists do to maximize the use of arteriovenous fistulas?
    Asif A; Lenz O; Merrill D; Pennell P
    Semin Dial; 2006; 19(3):203-5. PubMed ID: 16689969
    [No Abstract]   [Full Text] [Related]  

  • 29. Commentary on "Percutaneous interventions in dialysis access".
    Choi ET
    Perspect Vasc Surg Endovasc Ther; 2006 Dec; 18(4):322. PubMed ID: 17351200
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II).
    Mendelssohn DC; Ethier J; Elder SJ; Saran R; Port FK; Pisoni RL
    Nephrol Dial Transplant; 2006 Mar; 21(3):721-8. PubMed ID: 16311264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of primary failure in native AV-fistulae (early fistula failure).
    Ohira S; Kon T; Imura T
    Hemodial Int; 2006 Apr; 10(2):173-9. PubMed ID: 16623671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting balloon angioplasty: is it the key to access?
    Schainfeld RM
    Catheter Cardiovasc Interv; 2008 Feb; 71(2):255-7. PubMed ID: 18327844
    [No Abstract]   [Full Text] [Related]  

  • 33. The management and outcome of occluded haemodialysis access: a retrospective audit.
    Yehia M; McDonald M; Walker R
    N Z Med J; 2002 Nov; 115(1166):U258. PubMed ID: 12552276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.
    Bradbury BD; Chen F; Furniss A; Pisoni RL; Keen M; Mapes D; Krishnan M
    Am J Kidney Dis; 2009 May; 53(5):804-14. PubMed ID: 19268411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and infection rates of a polyurethane vascular access graft compared to tunnelled dialysis catheters and brachiobasilic arteriovenous fistulas.
    Wilmink T; Brown C; Richardson C; Claridge M; Ferring M; Rayner H; Smith S
    Nephrol Dial Transplant; 2006 May; 21(5):1453-4. PubMed ID: 16357053
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recurrent vascular access trombosis associated with the prothrombin mutation G20210A in a adult patient in haemodialysis].
    Quintana LF; Coll E; Monteagudo I; Collado S; López-Pedret J; Cases A
    Nefrologia; 2005; 25(4):442-4. PubMed ID: 16231514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New location for polytetrafluorethylene graft.
    Vilarasau M; Maillo A
    EDTNA ERCA J; 1996; 22(1):9-10. PubMed ID: 10723302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis.
    Coleman CI; Tuttle LA; Teevan C; Baker WL; White CM; Reinhart KM
    Int J Clin Pract; 2010 Aug; 64(9):1239-44. PubMed ID: 20455955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the femoral artery route for placement of temporary catheters for emergency haemodialysis when all usual central venous access sites are exhausted.
    Frampton AE; Kessaris N; Hossain M; Morsy M; Chemla ES
    Nephrol Dial Transplant; 2009 Mar; 24(3):913-8. PubMed ID: 18952702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural history of autogenous radio-cephalic wrist arteriovenous fistulas of haemodialysis patients: a prospective observational study.
    Basile C; Ruggieri G; Vernaglione L; Montanaro A; Giordano R
    Nephrol Dial Transplant; 2004 May; 19(5):1231-6. PubMed ID: 14993512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.